BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 20516645)

  • 1. Distinct roles for PTEN in prevention of T cell lymphoma and autoimmunity in mice.
    Liu X; Karnell JL; Yin B; Zhang R; Zhang J; Li P; Choi Y; Maltzman JS; Pear WS; Bassing CH; Turka LA
    J Clin Invest; 2010 Jul; 120(7):2497-507. PubMed ID: 20516645
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of T-cell lymphomagenesis in mice requires PTEN phosphatase activity.
    Newton RH; Lu Y; Papa A; Whitcher GH; Kang YJ; Yan C; Pandolfi PP; Turka LA
    Blood; 2015 Jan; 125(5):852-5. PubMed ID: 25477498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premalignant PTEN-deficient thymocytes activate microRNAs miR-146a and miR-146b as a cellular defense against malignant transformation.
    Burger ML; Xue L; Sun Y; Kang C; Winoto A
    Blood; 2014 Jun; 123(26):4089-100. PubMed ID: 24735967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. T-cell lymphomas in T-cell-specific Pten-deficient mice originate in the thymus.
    Hagenbeek TJ; Spits H
    Leukemia; 2008 Mar; 22(3):608-19. PubMed ID: 18046443
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High cancer susceptibility and embryonic lethality associated with mutation of the PTEN tumor suppressor gene in mice.
    Suzuki A; de la Pompa JL; Stambolic V; Elia AJ; Sasaki T; del Barco Barrantes I; Ho A; Wakeham A; Itie A; Khoo W; Fukumoto M; Mak TW
    Curr Biol; 1998 Oct; 8(21):1169-78. PubMed ID: 9799734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular context-dependent effects of H2ax and p53 deletion on the development of thymic lymphoma.
    Yin B; Yang-Iott KS; Chao LH; Bassing CH
    Blood; 2011 Jan; 117(1):175-85. PubMed ID: 20947684
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The loss of PTEN allows TCR alphabeta lineage thymocytes to bypass IL-7 and Pre-TCR-mediated signaling.
    Hagenbeek TJ; Naspetti M; Malergue F; Garçon F; Nunès JA; Cleutjens KB; Trapman J; Krimpenfort P; Spits H
    J Exp Med; 2004 Oct; 200(7):883-94. PubMed ID: 15452180
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine Pten(-/-) T-ALL requires non-redundant PI3K/mTOR and DLL4/Notch1 signals for maintenance and γc/TCR signals for thymic exit.
    Hagenbeek TJ; Wu X; Choy L; Sanchez-Irizarry C; Seshagiri S; Stinson J; Siebel CW; Spits H
    Cancer Lett; 2014 May; 346(2):237-48. PubMed ID: 24384093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of leukemia development caused by PTEN loss.
    Guo W; Schubbert S; Chen JY; Valamehr B; Mosessian S; Shi H; Dang NH; Garcia C; Theodoro MF; Varella-Garcia M; Wu H
    Proc Natl Acad Sci U S A; 2011 Jan; 108(4):1409-14. PubMed ID: 21212363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ribosomal Protein Rpl22 Controls the Dissemination of T-cell Lymphoma.
    Rao S; Cai KQ; Stadanlick JE; Greenberg-Kushnir N; Solanki-Patel N; Lee SY; Fahl SP; Testa JR; Wiest DL
    Cancer Res; 2016 Jun; 76(11):3387-96. PubMed ID: 27197189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RAG-mediated V(D)J recombination is not essential for tumorigenesis in Atm-deficient mice.
    Petiniot LK; Weaver Z; Vacchio M; Shen R; Wangsa D; Barlow C; Eckhaus M; Steinberg SM; Wynshaw-Boris A; Ried T; Hodes RJ
    Mol Cell Biol; 2002 May; 22(9):3174-7. PubMed ID: 11940674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Block of T cell development in P53-deficient mice accelerates development of lymphomas with characteristic RAG-dependent cytogenetic alterations.
    Haines BB; Ryu CJ; Chang S; Protopopov A; Luch A; Kang YH; Draganov DD; Fragoso MF; Paik SG; Hong HJ; DePinho RA; Chen J
    Cancer Cell; 2006 Feb; 9(2):109-20. PubMed ID: 16473278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of age at exposure on the inactivating mechanisms and relative contributions of key tumor suppressor genes in radiation-induced mouse T-cell lymphomas.
    Sunaoshi M; Amasaki Y; Hirano-Sakairi S; Blyth BJ; Morioka T; Kaminishi M; Shang Y; Nishimura M; Shimada Y; Tachibana A; Kakinuma S
    Mutat Res; 2015 Sep; 779():58-67. PubMed ID: 26141385
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Somatic inactivation of Tp53 in hematopoietic stem cells or thymocytes predisposes mice to thymic lymphomas with clonal translocations.
    DeMicco A; Yang-Iott K; Bassing CH
    Cell Cycle; 2013 Oct; 12(20):3307-16. PubMed ID: 24036547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell-specific loss of Pten leads to defects in central and peripheral tolerance.
    Suzuki A; Yamaguchi MT; Ohteki T; Sasaki T; Kaisho T; Kimura Y; Yoshida R; Wakeham A; Higuchi T; Fukumoto M; Tsubata T; Ohashi PS; Koyasu S; Penninger JM; Nakano T; Mak TW
    Immunity; 2001 May; 14(5):523-34. PubMed ID: 11371355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular abnormalities in lymphomas].
    Delsol G
    Bull Cancer; 2010 Nov; 97(11):1347-64. PubMed ID: 21084243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic interactions between Pten and p53 in radiation-induced lymphoma development.
    Mao JH; Wu D; Perez-Losada J; Nagase H; DelRosario R; Balmain A
    Oncogene; 2003 Nov; 22(52):8379-85. PubMed ID: 14627978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deletions in the long arm of chromosome 10 in lymphomas with t(14;18): a pathogenetic role of the tumor supressor genes PTEN/MMAC1 and MXI1?
    Siebert R; Gesk S; Harder S; Plötz S; Matthiesen P; Grote W; Schlegelberger B; Jandrig B; Grasmo-Wendler UH; Scherneck S; Rosenwald A; Ott G
    Blood; 1998 Dec; 92(11):4487-9. PubMed ID: 9882102
    [No Abstract]   [Full Text] [Related]  

  • 19. Fit αβ T-cell receptor suppresses leukemogenesis of Pten-deficient thymocytes.
    Gon S; Loosveld M; Crouzet T; Potier D; Bonnet M; Morin SO; Michel G; Vey N; Nunès JA; Malissen B; Roncagalli R; Nadel B; Payet-Bornet D
    Haematologica; 2018 Jun; 103(6):999-1007. PubMed ID: 29567770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Calcium Signaling Is Impaired in PTEN-Deficient T Cell Acute Lymphoblastic Leukemia.
    Pankaew S; Potier D; Grosjean C; Nozais M; Quessada J; Loosveld M; Remy É; Payet-Bornet D
    Front Immunol; 2022; 13():797244. PubMed ID: 35185889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.